Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility

S. R. Saklad, L. Ereshefsky, Michael Wong Jann, M. L. Crismon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.

Original languageEnglish
Pages (from-to)632-634
Number of pages3
JournalDrug Intelligence and Clinical Pharmacy
Volume18
Issue number7-8
DOIs
StatePublished - 1 Jan 1984

Fingerprint

Pharmacists
Psychiatry
Hospital Pharmacy Services
Antipsychotic Agents
Drug Utilization Review
Process Assessment (Health Care)
Patient Admission
Chlorpromazine
Cholinergic Antagonists
Pharmaceutical Preparations
Population
Delivery of Health Care
Therapeutics

Cite this

Saklad, S. R. ; Ereshefsky, L. ; Jann, Michael Wong ; Crismon, M. L. / Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility. In: Drug Intelligence and Clinical Pharmacy. 1984 ; Vol. 18, No. 7-8. pp. 632-634.
@article{3e0e7e58620544cebcfbcc75c03d6361,
title = "Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility",
abstract = "An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.",
author = "Saklad, {S. R.} and L. Ereshefsky and Jann, {Michael Wong} and Crismon, {M. L.}",
year = "1984",
month = "1",
day = "1",
doi = "10.1177/106002808401800718",
language = "English",
volume = "18",
pages = "632--634",
journal = "Drug Intelligence and Clinical Pharmacy",
issn = "0012-6578",
publisher = "Drug Intelligence and Clinical Pharmacy, Inc.",
number = "7-8",

}

Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility. / Saklad, S. R.; Ereshefsky, L.; Jann, Michael Wong; Crismon, M. L.

In: Drug Intelligence and Clinical Pharmacy, Vol. 18, No. 7-8, 01.01.1984, p. 632-634.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical pharmacists' impact on prescribing in an acute adult psychiatric facility

AU - Saklad, S. R.

AU - Ereshefsky, L.

AU - Jann, Michael Wong

AU - Crismon, M. L.

PY - 1984/1/1

Y1 - 1984/1/1

N2 - An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.

AB - An analysis is presented of data collected to evaluate the impact of a clinical pharmacy service on an acute psychiatric admitting unit. Retrospective longitudinal drug utilization reviews (RLDUR) were performed one year apart (pre- and post-implementation of services) on the same treatment team. Process measures significantly affected include (percent reduction): total drugs/patient (33.9), number of antipsychotic drugs/patient (38.0), number of anticholinergic started on admission/patient (53.2), and number of doses/patient/d (42.4). Other drug-use parameters significantly affected include: a 42-percent increase in the mean dosage expressed as chlorpromazine equivalents, and a 47-percent reduction in the number of patients on low potency antipsychotic medications. Beneficial outcome was reflected by a faster rate of discharge or transfer to a less restrictive ward environment in the pharmacy study population. The study population also demonstrated a 55.8-percent decrease in their readmission rate to the facility over a one-year follow-up period. Clinical pharmacy services positively affect both process and outcome health care measures.

UR - http://www.scopus.com/inward/record.url?scp=0021148850&partnerID=8YFLogxK

U2 - 10.1177/106002808401800718

DO - 10.1177/106002808401800718

M3 - Article

C2 - 6745092

AN - SCOPUS:0021148850

VL - 18

SP - 632

EP - 634

JO - Drug Intelligence and Clinical Pharmacy

JF - Drug Intelligence and Clinical Pharmacy

SN - 0012-6578

IS - 7-8

ER -